This episode shares lessons from the Sisonke Study a phase 3B open label study that provided pre-emergency use access to the Johnson and Johnson vaccine to health workers in South Africa. Researchers share the scientific, regulatory and ethical considerations that were needed to move rapidly from a clinical trial setup to active vaccination sites.

Interviewer: Nqobizitha Ndlovu, Regional Director and Leadership Advisor, Adaptive Change Advisors